top of page

Search

SAMHSA to Issue Interim Measures If Buprenorphine Rule Delayed

Ann Tucker

Feb 17, 20231 min read

SAMHSA (2/10) -- HHS has says that if the SAMHSA is unable to complete rulemaking that allows providers in opioid treatment programs to continue to initiate buprenorphine following a telehealth visit before the May 11 end of the public health emergency, SAMHSA will enact interim measures to bridge any gap that may result after the PHE ends. Cont.

Recent Posts

New Practical Guide Released on Advising Patients on Using 988 vs. 911

SAMHSA [12/19] – SAMHSA has issued a new Practical Guide: Advising People on Using 988 Versus 911 to help in better understanding the...

New Mental Health Rule Introduces Employer Benefit Parity Test

Bloomberg Government [9/09] - The Biden administration is poised to issue a final rule toughening mandates for employer-sponsored health...

Sackler Family Risks Litigation After Supreme Court Rejects Purdue Pharma Settlement

Forbes [7/09] - Purdue Pharma went back to court this week after the Supreme Court thwarted the OxyContin maker’s...

댓글

Back to Top

bottom of page